Holdings
Diadema Partners LP
As of Jun 30, 2026, Diadema Partners LP reported 69 positions worth US$250M. Largest: United Therapeutics Corporation, Revolution Medicines, Inc. and Abivax Sa. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| United Therapeutics Corporation | 52,989 | US$28.7M | +25,686 | Jun 30, 2026 |
| Revolution Medicines, Inc. | 139K | US$26.1M | +58,346 | Jun 30, 2026 |
| Abivax Sa | 164K | US$21.6M | +87,700 | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 494K | US$19.1M | +171K | Jun 30, 2026 |
| Biomarin Pharmaceutical Inc. | 313K | US$17.9M | +165K | Jun 30, 2026 |
| Viking Therapeutics, Inc. | 442K | US$17.2M | −83,373 | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. | 272K | US$11.1M | new | Jun 30, 2026 |
| Kodiak Sciences Inc | 218K | US$8.5M | +25,155 | Jun 30, 2026 |
| 4d Molecular Therapeutics, Inc. | 571K | US$7.6M | new | Jun 30, 2026 |
| Arcus Biosciences, Inc. | 224K | US$6.9M | −14,332 | Jun 30, 2026 |